ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,114 | -44.6% | 483,200 | -37.3% | 0.02% | -35.3% |
| Q2 2023 | $23,691 | -49.5% | 770,700 | -40.8% | 0.03% | -45.2% |
| Q1 2023 | $46,871 | +36.5% | 1,300,900 | +49.7% | 0.06% | +31.9% |
| Q4 2022 | $34,343 | -99.5% | 869,000 | +372.5% | 0.05% | +487.5% |
| Q1 2022 | $7,165,000 | -77.5% | 183,900 | -77.0% | 0.01% | -80.0% |
| Q4 2021 | $31,844,000 | +12.4% | 799,100 | +2.0% | 0.04% | +8.1% |
| Q3 2021 | $28,319,000 | -16.6% | 783,600 | -5.4% | 0.04% | -11.9% |
| Q2 2021 | $33,964,000 | – | 828,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |